Target-Centered Drug Repurposing Predictions of Human Angiotensin-Converting Enzyme 2 (ACE2) and Transmembrane Protease Serine Subtype 2 (TMPRSS2) Interacting Approved Drugs for Coronavirus Disease 2019 (COVID-19) Treatment through a Drug-Target Interaction Deep Learning Model

Previously, our group predicted commercially available Food and Drug Administration (FDA) approved drugs that can inhibit each step of the replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using a deep learning-based drug-target interaction model called Molecule Transformer...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Yoonjung, Shin, Bonggun, Kang, Keunsoo, Park, Sungsoo, Beck, Bo Ram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698791/
https://www.ncbi.nlm.nih.gov/pubmed/33218024
http://dx.doi.org/10.3390/v12111325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698791/
https://www.ncbi.nlm.nih.gov/pubmed/33218024
http://dx.doi.org/10.3390/v12111325

Ejemplares similares